Pulmonary Tuberculosis in a Child with Hemoptysis and Indeterminate Rifampicin Resistance: A Case Report

Authors

  • Imtinan Khoirunnisa Universitas Lampung
  • Shinta Nareswari

DOI:

https://doi.org/10.53089/medula.v16i4.1968

Keywords:

Child tuberculosis, hemoptysis, indeterminate

Abstract

Tuberculosis (TB) in children remains a major contributor to global morbidity and mortality. Although clinical manifestations such as hemoptysis have been increasingly reported in adolescents, the primary diagnostic challenge in this case lies in the Molecular Rapid Test (TCM) GeneXpert result showing indeterminate rifampicin resistance. The patient's chest X-ray showed primary pulmonary TB, consistent with positive Mantoux and lipoarabinomannan (LAM) TB test results. TCM GeneXpert examination confirmed pulmonary TB bacteriologically, with MTB trace detected and indeterminate rifampicin resistance. In addition, Gram staining of sputum showed a mixed flora of bacteria and fungi, reflecting colonization or potential infection in the respiratory tract. The patient was diagnosed with bacteriologically confirmed pulmonary TB with hemoptysis and anemia due to chronic disease, and was well-nourished. Medical interventions included a first-line Anti-Tuberculosis Drug (OAT) regimen and symptomatic therapy. The patient's clinical outcome was excellent, characterized by the immediate cessation of hemoptysis post-tranexamic acid initiation and the achievement of overall clinical improvement during hospitalization.  Overall, indeterminate rifampicin in TCM with a low (trace) bacterial load requires thorough clinical correlation to guide timely therapy.

References

Kementerian Kesehatan RI. Petunjuk Teknis Tata Laksana Tuberkulosis Anak dan Remaja. Jakarta: Kementerian Kesehatan RI; 2023.

Naum R, Speed B. Hemoptysis in Pediatric Patients. Cureus. 2019;11(3):1-7.

Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y, Ryan J, Banada PP, Deshpande S, Shenai S, Gall A, Glass J, Krieswirth B, Schumacher SG, Nabeta P, Tukvadze N, Rodrigues C, Skrahina A, Tagliani E, Cirillo DM, Davidow A, Denkinger CM, Persing D, Kwiatkowski R, Jones M, Alland D. The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing. mBio. 2017;8(4):1-12.

Menteri Kesehatan RI. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. Indonesia: Menteri Kesehatan RI;2019.

Siddalingaiah N, Chawla K, Nagaraja SB, Hazra D. Risk factors for the development of tuberculosis among the pediatric population: a systematic review and meta-analysis. European journal of pediatrics. 2023;182(7):3007-3019.

Faisal HKP, Yunus F, Rahajoe N. Pediatric Hemoptysis. J Respir Indones. 2021;41(3):214–20.

Pereira NMD. Clinical profile and outcome of children with tuberculosis in a tertiary care hospital in Mumbai, India. Sri Lanka J Child Health. 2019;48(4):338-44.

Chiang SS, Graham SM, Schaaf HS, Marais BJ, Sant'Anna CC, Sharma S, Starke JR, Triasih R, Achar J, Amanullah F, Armitage LY, Aurilio RB, Buck WC, Centis R, Chabala C, Cruz AT, Dermes AM, du PK, Enimil A, Furin J, Migliori GB. Clinical standards for drug-susceptible TB in children and adolescents. Int J Tuberc Lung Dis. 2023; 27(8):584-98.

Lanser L, Fuchs D, Kurz K, Weiss G. Physiology and Inflammation Driven Pathophysiology of Iron Homeostasis-Mechanistic Insights into Anemia of Inflammation and Its Treatment. Nutrients. 2021;13(11):3732

Rokkam VR, Kileen RB, Kotagiri R. Secondary Thrombocytosis. StatPearls; 2024

Ghaesani NM, Effendy RR, Wulandari DA. Radiological Findings of Pulmonary Tuberculosis in Children at Dr. Hasan Sadikin General Hospital Bandung 2018-2019. Althea Medical Journal. 2021;8(4):198-203.

World Health Organization. WHO consolidated guidelines on tuberculosis. Module 5: Management of tuberculosis in children and adolescents. Geneva: World Health Organization; 2022.

Seid G, Alemu A, Tsedalu T, Dagne B. Value of urine-based lipoarabinomannan (LAM) antigen tests for diagnosing tuberculosis in children: systematic review and meta-analysis. IJID Reg. 2022; 23(4):97-104.

Eksa DR. Analisis Komparatif Pemeriksaan Lateral Flow Lipoarabinomanan (Lf-Lam) Dibandingkan Xpert Mtb/Rif pada Pasien Tuberkulosis Paru Dengan Malnutrisi di RSUD Dr. H. Abdul Moeloek Provinsi Lampung [tesis]. Bandar Lampung: Universitas Lampung; 2025

Sinulingga CP, Sinaga BYM, Siagian P, Yunita R, Wahyuni AS. Infeksi Bakteri dan Jamur pada Pasien Tuberkulosis Paru dan Pola Uji Sensitivitas Obat. Afr J Infect Dis. 2024;19(1):21-28.

World Health Organization. Xpert MTB/RIF implementation manual: technical and operational how-to; practical considerations. Geneva: World Health Organization; 2014.

Centers for Disease Control and Prevention. Xpert MTB/RIF Assay. CDC;2024.

World Health Organization. WHO operational handbook on tuberculosis. Module 3: Diagnosis. Geneva: World Health Organization; 2021.

Published

2026-06-23

How to Cite

Khoirunnisa, I., & Shinta Nareswari. (2026). Pulmonary Tuberculosis in a Child with Hemoptysis and Indeterminate Rifampicin Resistance: A Case Report . Medical Profession Journal of Lampung, 16(4), 173-180. https://doi.org/10.53089/medula.v16i4.1968

Issue

Section

Artikel